haloperidol has been researched along with Stuttering in 24 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Stuttering: A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In studies of the acute effects of haloperidol on the severity of stuttering in 12 subjects not in treatment at the time of drug evaluation, a single 0." | 9.04 | The acute effect of haloperidol and apomorphine on the severity of stuttering. ( Brady, JP; Burns, D; Kuruvilla, K, 1978) |
| "Haloperidol treatment for stuttering was examined in a double-blind cross-over study of 26 adult volunteers with long-standing stuttering." | 5.04 | Haloperiodl in the treatment of stuttering. ( Campbell, L; Kelly, P; Murray, TJ; Stefanik, K, 1977) |
| "In studies of the acute effects of haloperidol on the severity of stuttering in 12 subjects not in treatment at the time of drug evaluation, a single 0." | 5.04 | The acute effect of haloperidol and apomorphine on the severity of stuttering. ( Brady, JP; Burns, D; Kuruvilla, K, 1978) |
| "The etiology of stuttering is controversial." | 2.40 | Stuttering: a brief review. ( Barclay, DM; Lawrence, M, 1998) |
| "Therapeutic plasma monitoring of haloperidol, a major neuroleptic, measured by radioimmunoassay, has shown a rather good correlation between plasma level and dosage but with large interindividual variation in children as in adults; age seems not to have any effect on haloperidol metabolism." | 1.27 | [Haloperidol. Plasma monitoring and hormonal effects of treatment]. ( Debray, Q; Dugas, M; Giraud, J; Goyot, C; Grenier, J; Guay, C, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (83.33) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Sood, S | 1 |
| McAllister, MW | 1 |
| Woodhall, DM | 1 |
| Prins, D | 1 |
| Mandelkorn, T | 1 |
| Cerf, FA | 1 |
| Spehr, W | 1 |
| Andresen, B | 1 |
| Pascher, W | 1 |
| Wood, F | 1 |
| Stump, D | 1 |
| McKeehan, A | 1 |
| Sheldon, S | 1 |
| Proctor, J | 1 |
| Lawrence, M | 1 |
| Barclay, DM | 1 |
| Murray, TJ | 1 |
| Kelly, P | 1 |
| Campbell, L | 1 |
| Stefanik, K | 1 |
| Burns, D | 1 |
| Brady, JP | 2 |
| Kuruvilla, K | 1 |
| Rantala, SL | 1 |
| Petri-Larmi, M | 1 |
| Barker, P | 1 |
| Wells, PG | 4 |
| Goyot, C | 1 |
| Debray, Q | 1 |
| Dugas, M | 1 |
| Guay, C | 1 |
| Giraud, J | 1 |
| Grenier, J | 1 |
| Sirtori, C | 1 |
| Valdivieso, A | 1 |
| Quinn, PT | 2 |
| Peachey, EC | 1 |
| Cookson, IB | 1 |
| Peachey, C | 1 |
| Healy, CE | 1 |
| Tapia, F | 1 |
| Malcolm, MT | 1 |
2 reviews available for haloperidol and Stuttering
| Article | Year |
|---|---|
Stuttering: a brief review.
Topics: Haloperidol; Humans; Stuttering | 1998 |
The pharmacology of stuttering: a critical review.
Topics: Antipsychotic Agents; Benzodiazepines; Calcium Channel Blockers; Haloperidol; Humans; Parasympathomi | 1991 |
8 trials available for haloperidol and Stuttering
| Article | Year |
|---|---|
Principal and differential effects of haoperidol and placebo treatments upon speech disfuluencies in stutterers.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Fem | 1980 |
Haloperiodl in the treatment of stuttering.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Middle Aged; Placebo | 1977 |
The acute effect of haloperidol and apomorphine on the severity of stuttering.
Topics: Adolescent; Adult; Apomorphine; Brain; Dopamine; Double-Blind Method; Drug Evaluation; Female; Halop | 1978 |
Haloperidol (Serenase) in the treatment of stuttering.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Drug Evaluation; Female; Haloperidol; Humans; Ma | 1976 |
Haloperidol in the treatment of stutterers.
Topics: Anxiety; Clinical Trials as Topic; Haloperidol; Humans; Stuttering | 1973 |
Letter: Haloperidol in stuttering.
Topics: Child; Clinical Trials as Topic; Female; Haloperidol; Humans; Stuttering | 1974 |
Haldol in the treatment of children with tics and stutterers and an incidental finding.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Haloperidol; Humans; Placebos; Stuttering; Tic Di | 1969 |
Controlled trial of the treatment of 36 stutterers.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Intelligence Tests; Male; | 1971 |
14 other studies available for haloperidol and Stuttering
| Article | Year |
|---|---|
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Haloperidol; Humans; Male; Risperidone; Stutt | 2022 |
Bupropion-induced stuttering treated with haloperidol.
Topics: Bupropion; Emergency Service, Hospital; Haloperidol; Humans; Male; Middle Aged; Stuttering | 2016 |
The impact of long-time, low-dosage haloperidol therapy on anxiety proneness.
Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Male; Stuttering | 1981 |
Patterns of regional cerebral blood flow during attempted reading aloud by stutterers both on and off haloperidol medication: evidence for inadequate left frontal activation during stuttering.
Topics: Adult; Cerebrovascular Circulation; Female; Functional Laterality; Haloperidol; Humans; Male; Readin | 1980 |
Haloperidol.
Topics: Child; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Intellectual Disability; Stuttering; Tic | 1975 |
Letter: haloperiodol in the treatment of stutter.
Topics: Dose-Response Relationship, Drug; Haloperidol; Humans; Stuttering; Time Factors | 1975 |
[Haloperidol. Plasma monitoring and hormonal effects of treatment].
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; beta-Endorphin; Child; Delayed-Action Pr | 1985 |
Letter: Haloperidol in the treatment of stutter.
Topics: Haloperidol; Humans; Stuttering | 1974 |
[Collecting of the news].
Topics: Aging; Air Pollution; Haloperidol; Health Education; Humans; Italy; Myocardial Infarction; Neoplasms | 1974 |
[Experience with haloperidol and thioridazine in stuttering children].
Topics: Child; Child, Preschool; Drug Evaluation; Haloperidol; Humans; Stuttering; Tablets; Thioridazine | 1974 |
Letter: Haloperidol in the treatment of stutterers.
Topics: Depression; Ethanol; Haloperidol; Humans; Piperazines; Sleep; Stuttering; Substance Withdrawal Syndr | 1973 |
Stuttering. An investigation of haloperidol.
Topics: Adolescent; Adult; Anxiety; Haloperidol; Humans; Orphenadrine; Stuttering; Trifluoperazine | 1973 |
Letter: Possible remedy for stuttering.
Topics: Adolescent; Female; Haloperidol; Humans; Stuttering | 1974 |
Stuttering.
Topics: Adolescent; Adult; Behavior Therapy; Child; Child, Preschool; Counseling; Haloperidol; Humans; Middl | 1972 |